Ring, A.; Nguyen, C.; Smbatyan, G.; Tripathy, D.; Yu, M.; Press, M.; Kahn, M.; Lang, J.E.
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer. Cancers 2018, 10, 525.
https://doi.org/10.3390/cancers10120525
AMA Style
Ring A, Nguyen C, Smbatyan G, Tripathy D, Yu M, Press M, Kahn M, Lang JE.
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer. Cancers. 2018; 10(12):525.
https://doi.org/10.3390/cancers10120525
Chicago/Turabian Style
Ring, Alexander, Cu Nguyen, Goar Smbatyan, Debu Tripathy, Min Yu, Michael Press, Michael Kahn, and Julie E. Lang.
2018. "CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer" Cancers 10, no. 12: 525.
https://doi.org/10.3390/cancers10120525
APA Style
Ring, A., Nguyen, C., Smbatyan, G., Tripathy, D., Yu, M., Press, M., Kahn, M., & Lang, J. E.
(2018). CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer. Cancers, 10(12), 525.
https://doi.org/10.3390/cancers10120525